Browse Paid Medical Studies

Additional Information

This study is for an investigational drug being developed to reduce the risk of cardiovascular (CV) events in patients with high triglyceride (a type of lipid or fat) levels who are at high CV risk.

Covance Dallas is currently seeking:

• Healthy Adults, Age 18-65 who have high triglyceride levels and not currently taking medications

• Women must be postmenopausal or surgically sterile

• BMI (body mass index) 18.5-40

• Available for 1 clinic stay of 4 overnights followed by 7 outpatient visits

• Receive a $50 screening payment. Qualified participants may be compensated up to $5,944 for time and participation

*Triglycerides are a type of fat often measured with cholesterol in the blood.

Details

Screening: Nov 5, 7, 8, 11, 12, 14, 15, 18

Check-in: Nov 20

Check-out: Feb 13

Outpatient Visit: Nov 24, 28,

Dec 5, 12, 19,

Jan 2, 16, Feb 13

Additional Information

This is a research study for Denosumab, a commercially available drug marketed as Prolia® or Xgeva® and used to treat conditions of the bones, such as osteoporosis and the prevention of skeletal-related events in solid tumors. The purpose of this study is to compare the blood levels of the approved formulation to an investigational formulation.

• Healthy Non-Smoking Adults, age 18-65

• BMI (body mass index) 18-30

• Join us for a stay of 8 nights followed by 11 outpatient visits

• Compensation up to $7658 may be provided for time and participation

Details

Details:

Screening: Nov 12, 13, 14, 15, 18, 19, 20, 21, 22, 25, 26

Check-in: Dec 9

Check-out: Dec 17

Outpatient Visits: Dec 20, 24, 31; Jan 7, 21; Feb 4, 18; Mar 3, 17, 31; Apr 14

Additional Information

The purpose of this study is to evaluate the safety and side effects of multiple doses of the study drug in participants with nonalcoholic fatty liver disease (NAFLD).

Covance Dallas is currently recruiting for:

• Adults, age 18-60.

• Women must be surgically sterile or postmenopausal

• BMI (body mass index) 30-38

• Available for 3 screening visits, 1 stay of 30 overnights & up to 5 outpatient visits

• Compensation ranges from $7,370-$8,270 for time and participation

Details

Screening Dates: Nov 4, 5, 7, 18, 19, 20, 21, 22, 25, 26, 27

Dec 2, 3, 4, 5, 6

Check-In: Nov 18
Check-Out: Dec 18
Outpatient Visits: Dec 30, Jan 13, 27, Feb 10

Additional Information

This is a research study for an investigational drug being developed for immune-mediated inflammatory disorders such as eczema or inflammatory bowel disease (IBD)

Volunteers must be:

•Healthy Adults, Ages 18-55

•BMI (body mass index) 18-32

•Join us for 5 overnights and 1 outpatient visit

•Compensation up to $2,898 may be provided for time and participation

Details

Group: A2

Screening: Nov 12, 13, 14

Check-in: Nov 21

Check-in: Nov 26

Outpatient Visit: Dec 2

Call us today to schedule your screening appointment!

Additional Information

This is a research study for an investigational drug being developed for immune-mediated inflammatory disorders such as eczema or inflammatory bowel disease (IBD)

Volunteers must be:

•Healthy Adults, Ages 18-55

•BMI (body mass index) 18-32

•Join us for 5 overnights and 1 outpatient visit

•Compensation up to $2,898 may be provided for time and participation

Details

Group: A1

Screening: Nov 11

Check-in: Nov 17

Check-out: Nov 22

Outpatient Visit: Nov 27

Call us today to schedule your screening appointment!

Additional Information

You may qualify for research study 8374-568 and receive up to $4,650

• Non-Smoking Adults, diagnosed with Parkinson’s Disease
• Age 50-75
• Volunteers must be available for 4 study visits
• Compensation up to $4,650 may be provided for time and participation

Call us today! - (469) 914-8330

Details

Screening dates: Oct 23, 24, 29, 31; Nov 5, 6, 12, 13, 19, 21, 26